Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 218

1.

Trypanosoma cruzi benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease.

Moreno M, D'ávila DA, Silva MN, Galvão LM, Macedo AM, Chiari E, Gontijo ED, Zingales B.

Mem Inst Oswaldo Cruz. 2010 Nov;105(7):918-24.

2.

Impact of dual infections on chemotherapeutic efficacy in BALB/c mice infected with major genotypes of Trypanosoma cruzi.

Martins HR, Silva RM, Valadares HM, Toledo MJ, Veloso VM, Vitelli-Avelar DM, Carneiro CM, Machado-Coelho GL, Bahia MT, Martins-Filho OA, Macedo AM, Lana M.

Antimicrob Agents Chemother. 2007 Sep;51(9):3282-9. Epub 2007 Jul 16.

3.

Variation in susceptibility to benznidazole in isolates derived from Trypanosoma cruzi parental strains.

Veloso VM, Carneiro CM, Toledo MJ, Lana M, Chiari E, Tafuri WL, Bahia MT.

Mem Inst Oswaldo Cruz. 2001 Oct;96(7):1005-11.

4.

Trypanosoma cruzi: Immunological predictors of benznidazole efficacy during experimental infection.

Fernández MC, González Cappa SM, Solana ME.

Exp Parasitol. 2010 Feb;124(2):172-80. doi: 10.1016/j.exppara.2009.09.006. Epub 2009 Sep 9.

PMID:
19747482
5.
6.

Benznidazole therapy during acute phase of Chagas disease reduces parasite load but does not prevent chronic cardiac lesions.

Caldas IS, Talvani A, Caldas S, Carneiro CM, de Lana M, da Matta Guedes PM, Bahia MT.

Parasitol Res. 2008 Jul;103(2):413-21. doi: 10.1007/s00436-008-0992-6. Epub 2008 May 4.

PMID:
18454349
7.

Trypanosoma cruzi: chemotherapy with benznidazole in mice inoculated with strains from Paraná state and from different endemic areas of Brazil.

Toledo MJ, Guilherme AL, da Silva JC, de Gasperi MV, Mendes AP, Gomes ML, de Araújo SM.

Rev Inst Med Trop Sao Paulo. 1997 Sep-Oct;39(5):283-90.

PMID:
9661307
8.
9.

In vivo susceptibility to benznidazole of Trypanosoma cruzi strains from the western Brazilian Amazon.

Teston AP, Monteiro WM, Reis D, Bossolani GD, Gomes ML, de Araújo SM, Bahia MT, Barbosa MG, Toledo MJ.

Trop Med Int Health. 2013 Jan;18(1):85-95. doi: 10.1111/tmi.12014. Epub 2012 Nov 6.

10.

In vivo selection of a population of Trypanosoma cruzi and clones resistant to benznidazole.

Murta SM, Romanha AJ.

Parasitology. 1998 Feb;116 ( Pt 2):165-71.

PMID:
9509026
11.

The dog as model for chemotherapy of the Chagas' disease.

Guedes PM, Veloso VM, Tafuri WL, Galvão LM, Carneiro CM, Lana Md, Chiari E, Ataide Soares K, Bahia MT.

Acta Trop. 2002 Oct;84(1):9-17.

PMID:
12387906
12.

New, combined, and reduced dosing treatment protocols cure Trypanosoma cruzi infection in mice.

Bustamante JM, Craft JM, Crowe BD, Ketchie SA, Tarleton RL.

J Infect Dis. 2014 Jan 1;209(1):150-62. doi: 10.1093/infdis/jit420. Epub 2013 Aug 14.

13.

Changes of RAPD profile of Trypanosoma cruzi II with Canova and Benznidazole.

Aleixo DL, Ferraz FN, de Melo CS, Gomes ML, Toledo MJ, Kaneshima EN, Bersani-Amado CA, Araújo SM.

Homeopathy. 2008 Apr;97(2):59-64. doi: 10.1016/j.homp.2008.02.003.

PMID:
18439965
14.

Combined treatment of heterocyclic analogues and benznidazole upon Trypanosoma cruzi in vivo.

Batista Dda G, Batista MM, de Oliveira GM, Britto CC, Rodrigues AC, Stephens CE, Boykin DW, Soeiro Mde N.

PLoS One. 2011;6(7):e22155. doi: 10.1371/journal.pone.0022155. Epub 2011 Jul 26.

15.

Trypanosoma cruzi: Induction of benznidazole resistance in vivo and its modulation by in vitro culturing and mice infection.

Dos Santos FM, Caldas S, de Assis Cáu SB, Crepalde GP, de Lana M, Machado-Coelho GL, Veloso VM, Bahia MT.

Exp Parasitol. 2008 Dec;120(4):385-90. doi: 10.1016/j.exppara.2008.09.007. Epub 2008 Sep 14.

PMID:
18823980
16.

Chemotherapy with benznidazole and itraconazole for mice infected with different Trypanosoma cruzi clonal genotypes.

Toledo MJ, Bahia MT, Carneiro CM, Martins-Filho OA, Tibayrenc M, Barnabé C, Tafuri WL, de Lana M.

Antimicrob Agents Chemother. 2003 Jan;47(1):223-30.

17.

Complexation of the anti-Trypanosoma cruzi drug benznidazole improves solubility and efficacy.

Nogueira Silva JJ, Pavanelli WR, Gutierrez FR, Alves Lima FC, Ferreira da Silva AB, Santana Silva J, Wagner Franco D.

J Med Chem. 2008 Jul 24;51(14):4104-14. doi: 10.1021/jm701306r. Epub 2008 Jun 21.

PMID:
18570370
18.

Experimental benznidazole treatment of Trypanosoma cruzi II strains isolated from children of the Jequitinhonha Valley, Minas Gerais, Brazil, with Chagas disease.

Oliveira-Silva JC, Machado-de-Assis GF, Oliveira MT, Paiva NC, Araújo MS, Carneiro CM, Martins-Filho OA, Martins HR, Lana Md.

Mem Inst Oswaldo Cruz. 2015 Feb;110(1):86-94. doi: 10.1590/0074-02760140260. Epub 2015 Jan 23.

19.

Response to chemotherapy with benznidazole of clones isolated from the 21SF strain of Trypanosoma cruzi (biodeme Type II, Trypanosoma cruzi II).

Campos RF, Guerreiro ML, Sobral Kde S, Lima Rde C, Andrade SG.

Rev Soc Bras Med Trop. 2005 Mar-Apr;38(2):142-6. Epub 2005 Mar 30.

20.

Nitric oxide donor trans-[RuCl([15]aneN)NO] as a possible therapeutic approach for Chagas' disease.

Guedes PM, Oliveira FS, Gutierrez FR, da Silva GK, Rodrigues GJ, Bendhack LM, Franco DW, Do Valle Matta MA, Zamboni DS, da Silva RS, Silva JS.

Br J Pharmacol. 2010 May;160(2):270-82. doi: 10.1111/j.1476-5381.2009.00576.x. Epub 2010 Jan 27.

Items per page

Supplemental Content

Write to the Help Desk